GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » YoY Rev. per Sh. Growth

Neuroscientific Biopharmaceuticals (ASX:NSB) YoY Rev. per Sh. Growth : -100.00% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Neuroscientific Biopharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -100.00%.

Neuroscientific Biopharmaceuticals's Revenue per Share for the six months ended in Dec. 2023 was A$0.00.

Neuroscientific Biopharmaceuticals YoY Rev. per Sh. Growth Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals YoY Rev. per Sh. Growth Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
YoY Rev. per Sh. Growth
- - - - -

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -100.00

Neuroscientific Biopharmaceuticals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Neuroscientific Biopharmaceuticals's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2023 )
=(Revenue per Share (A: Jun. 2023 )-Revenue per Share (A: Jun. 2022 ))/ | Revenue per Share (A: Jun. 2022 ) |
=(0-0)/ | 0 |
=N/A %

Neuroscientific Biopharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0-0.008)/ | 0.008 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ASX:1AD ASX:ZLD ASX:MEM ASX:AVE ASX:ILA ASX:NC6 ASX:ACR ASX:EX1 ASX:BGT ASX:HXL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Website
https://www.neuroscientific.com
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines